FT536

· Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FT536, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]